The startling findings raise the possibility that the medicines, originally developed to treat diabetes, could one day be ...

The FDA’s recent approval of OZEMPIC highlights the expanding use of GLP-1 drugs beyond diabetes and weight management. Novo Nordisk’s blockbuster medication has gained another label expansion, now ...

Users were quick to highlight one strikingly similar feature prolific among the A-listers gathered in Los Angeles - ...

Elon Musk wants to cut funding for scientific research, but the weight loss drugs he promoted also came from government funded basic science.

People using semaglutide for diabetes or weight loss have also reported experiencing a reduced desire for alcohol.

New York, USA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Novo Nordisk's OZEMPIC Approval Heat Up the Chronic Kidney disease Therapeutic market | DelveInsight The FDA's recent approval of OZEMPIC ...

This will be a “pivotal year,” one expert says, for GLP-1 drugs, which are massively disrupting the benefits landscape.

David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous value they offer.

Polar Capital Global Healthcare, which is co-managed by James Douglas, currently trades at a 3pc discount to its assets.

The country's foremost expert on obesity has urged the Health Service Executive to make the 'King Kong' of weight loss drugs available free of charge.